TY - CHAP M1 - Book, Section TI - Age-Related Macular Degeneration A1 - Duncan, Jacque L. A1 - Parikh, Neeti B. A1 - Seitzman, Gerami D. A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. A2 - McQuaid, Kenneth R. PY - 2022 T2 - Current Medical Diagnosis & Treatment 2022 AB - KEY CLINICAL UPDATE IN AGE-RELATED MACULAR DEGENERATIONBrolucizumab, an inhibitor of vascular endothelial growth factor, has been associated with intraocular inflammation and occlusive retinal vasculitis resulting in irreversible vision loss in some patients. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/content.aspx?aid=1184192277 ER -